Kamal El Bissati to Drug Resistance
This is a "connection" page, showing publications Kamal El Bissati has written about Drug Resistance.
Connection Strength
0.049
-
New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections. Sci Rep. 2016 07 14; 6:29179.
Score: 0.032
-
Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and its analog ZL3B. BMC Clin Pharmacol. 2007 Oct 23; 7:13.
Score: 0.017